EXACT Sciences Corp. (EXAS)
101.50
+0.14
(+0.14%)
USD |
NASDAQ |
Dec 12, 16:00
101.40
-0.10
(-0.10%)
After-Hours: 20:00
EXACT Sciences Research and Development Expense (Quarterly): 117.22M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Guardant Health, Inc. | 89.96M |
| Natera, Inc. | 173.41M |
| Illumina, Inc. | 228.00M |
| Fulgent Genetics, Inc. | 13.86M |
| Delcath Systems, Inc. | 7.986M |